Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1453

1.

Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.

Gordon E, Lazarus SC.

J Allergy Clin Immunol. 2009 Nov;124(5):873-80; quiz 881-2. doi: 10.1016/j.jaci.2009.09.040. Review.

PMID:
19895979
2.

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium..

Ann Intern Med. 2007 Apr 17;146(8):545-55.

PMID:
17310045
4.

[Combination of inhaled salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial].

Fang LZ, Liang X, Zhang JQ, Liu L, Fu WP, Zhao ZH, Dai LM.

Zhonghua Jie He He Hu Xi Za Zhi. 2008 Nov;31(11):811-4. Chinese.

PMID:
19080533
5.

Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.

Chung KF, Caramori G, Adcock IM.

Eur J Clin Pharmacol. 2009 Sep;65(9):853-71. doi: 10.1007/s00228-009-0682-z. Review.

PMID:
19557399
6.

Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.

Baker WL, Baker EL, Coleman CI.

Pharmacotherapy. 2009 Aug;29(8):891-905. doi: 10.1592/phco.29.8.891.

PMID:
19637942
7.

Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.

Anzueto A.

Am J Med. 2006 Oct;119(10 Suppl 1):46-53. Review.

PMID:
16996899
8.

Tiotropium bromide: a novel once-daily anticholinergic bronchodilator for the treatment of COPD.

Hansel TT, Barnes PJ.

Drugs Today (Barc). 2002 Sep;38(9):585-600. Review.

PMID:
12582447
9.
10.

Fluticasone propionate/salmeterol for the treatment of chronic-obstructive pulmonary disease.

Dransfield MT, Bailey WC.

Expert Opin Pharmacother. 2004 Aug;5(8):1815-26. Review.

PMID:
15264996
11.

Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD.

Schermer TR, Albers JM, Verblackt HW, Costongs RJ, Westers P.

Fam Pract. 2007 Apr;24(2):181-8.

PMID:
17251178
13.

[Inhaled corticosteroids in patients with COPD: maintain current guidelines].

Heijdra YF.

Ned Tijdschr Geneeskd. 2007 Oct 6;151(40):2195-7. Dutch.

PMID:
17969568
14.

Seretide for obstructive lung disease.

Chapman KR.

Expert Opin Pharmacother. 2002 Mar;3(3):341-50. Review.

PMID:
11866683
15.

Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology.

Seemungal T, Stockley R, Calverley P, Hagan G, Wedzicha JA.

COPD. 2007 Sep;4(3):177-83.

PMID:
17729060
16.

Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.

Kurashima K, Hara K, Yoneda K, Kanauchi T, Kagiyama N, Tokunaga D, Takayanagi N, Ubukata M, Sugita Y.

Respirology. 2009 Mar;14(2):239-44. doi: 10.1111/j.1440-1843.2008.01452.x.

PMID:
19210650
17.

[Triple therapy in chronic obstructive pulmonary disease].

Baloira A.

Arch Bronconeumol. 2010;46 Suppl 8:25-30. doi: 10.1016/S0300-2896(10)70064-8. Review. Spanish.

18.

Seretide: a pharmacoeconomic analysis.

Fritscher L, Chapman KR.

J Med Econ. 2008;11(3):555-70. doi: 10.3111/13696990802320908. Review.

PMID:
19450105
19.
20.

Pharmacologic treatment of chronic obstructive pulmonary disease: past, present, and future.

Faulkner MA, Hilleman DE.

Pharmacotherapy. 2003 Oct;23(10):1300-15. Review.

PMID:
14594347

Supplemental Content

Support Center